The first-of-its-kind test can rapidly assess how effective different polyethylene glycol (PEG) based nanomedicines are at killing cancer cells and minimising side effects using just a drop of blood from people with leukemia, a type of blood cancer.
Researchers have developed microchips using field-effect transistors that can detect multiple diseases from a single air sample with high sensitivity. The technology enables rapid testing and could lead to portable diagnostic devices for home and medical use.
